Zheng Du Huaqi Yin Shiming Zhao Yongkang Ma Zhenghui Sun Bingqi Dong Mingkai Zhu Chaoshuai Zhu Jiangshan Peng Tiejun Yang
10.3389/fonc.2022.1062655
Front Oncol
2022 Dec 23;12:1062655.
bladder hyperthermia chemotherapy gemcitabine muscle invasive bladder urothelium carcinoma tislelizumab tumor immunotherapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/36620538/
Case Reports
PMC9816863
36620538
Case report: Gemcitabine intravesical hyperthermic infusion combined with tislelizumab in muscle invasive bladder urothelium carcinoma
2022